NO973589L - Drugs for the treatment of obsessive-compulsive disorder, sleep apnea, sexual dysfunction, emesis and travel sickness - Google Patents

Drugs for the treatment of obsessive-compulsive disorder, sleep apnea, sexual dysfunction, emesis and travel sickness

Info

Publication number
NO973589L
NO973589L NO973589A NO973589A NO973589L NO 973589 L NO973589 L NO 973589L NO 973589 A NO973589 A NO 973589A NO 973589 A NO973589 A NO 973589A NO 973589 L NO973589 L NO 973589L
Authority
NO
Norway
Prior art keywords
emesis
obsessive
treatment
sleep apnea
sexual dysfunction
Prior art date
Application number
NO973589A
Other languages
Norwegian (no)
Other versions
NO973589D0 (en
Inventor
Jordi Frigola Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO973589D0 publication Critical patent/NO973589D0/en
Publication of NO973589L publication Critical patent/NO973589L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Oppfinnelsen angår anvendelse av derivater av 1 {4- [4-aryl (eller heteroaryl) -l-piperazinyl]butyI}-lH-azol så vel som fysiologisk akseptable salter derav for fremstilling av medikamenter som er ment for behandling av tvangstanke-tvangshandlingslidelser, sovnapne, seksuelle dysfunksjoner, emesis og transportsykdommer.The invention relates to the use of derivatives of 1 {4- [4-aryl (or heteroaryl) -1-piperazinyl] butyl} -1H-azole as well as physiologically acceptable salts thereof for the manufacture of medicaments intended for the treatment of obsessive-compulsive disorder. sleep apnea, sexual dysfunction, emesis and transport disorders.

NO973589A 1995-12-12 1997-08-04 Drugs for the treatment of obsessive-compulsive disorder, sleep apnea, sexual dysfunction, emesis and travel sickness NO973589L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (en) 1995-12-12 1995-12-12 USE OF DERIVATIVES 1- (4- (4-ARYL (OR HETEROARYL) -1-PIPER AZINYL) -BUTY) -1H-AZOLE FOR THE TREATMENT OF DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS, SLEEP APNEA, SEXUAL DYSFUNCTIONS , Emese and motion sickness
PCT/EP1996/005736 WO1997021439A1 (en) 1995-12-12 1996-12-11 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness

Publications (2)

Publication Number Publication Date
NO973589D0 NO973589D0 (en) 1997-08-04
NO973589L true NO973589L (en) 1997-10-08

Family

ID=9485400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973589A NO973589L (en) 1995-12-12 1997-08-04 Drugs for the treatment of obsessive-compulsive disorder, sleep apnea, sexual dysfunction, emesis and travel sickness

Country Status (16)

Country Link
EP (1) EP0808166A1 (en)
JP (1) JPH11501051A (en)
CN (1) CN1177297A (en)
AR (1) AR004378A1 (en)
AU (1) AU716665B2 (en)
CA (1) CA2211161A1 (en)
CZ (1) CZ255197A3 (en)
ES (1) ES2134709B1 (en)
FR (1) FR2742052B1 (en)
HU (1) HUP9800198A2 (en)
IL (1) IL121461A0 (en)
NO (1) NO973589L (en)
PL (1) PL321779A1 (en)
TR (1) TR199700794T1 (en)
WO (1) WO1997021439A1 (en)
ZA (1) ZA9610457B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763950B1 (en) * 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4- (4,5-DICHLORO-2-METHYLIMIDAZOL-1-YL) BUTYL] -1- PIPERAZINYL} -5-FLUOROPYRIMIDINE, ITS PREPARATION AND THERAPEUTIC USE
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
JP5140225B2 (en) 2000-08-14 2013-02-06 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Substituted pyrazoles
JP5049447B2 (en) 2000-08-14 2012-10-17 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
WO2002014317A2 (en) 2000-08-14 2002-02-21 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
MXPA03001960A (en) 2000-09-06 2004-03-18 Johnson & Johnson A method for treating allergies.
CA2580730C (en) 2003-09-25 2015-01-13 Cenomed, Inc. Tetrahydroindolone derivatives for treatment of neurological conditions
WO2005094827A1 (en) * 2004-03-30 2005-10-13 Kestrel Pharmaceuticals Inc. Methods for treating sexual dysfunction
WO2006116615A1 (en) 2005-04-26 2006-11-02 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
ATE461925T1 (en) 2005-04-26 2010-04-15 Hypnion Inc BENZISOXAZOLEPIPERIDINE COMPOUNDS AND METHOD FOR USE THEREOF
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
CN115304590A (en) * 2022-09-19 2022-11-08 皮摩尔新药(辽宁)有限公司 2H-benzotriazole derivatives, preparation method thereof and pharmaceutical composition containing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (en) * 1991-01-28 1995-05-24 Esteve Labor Dr DERIVATIVES OF ARYL (OR HETEROARYL) -PIPERAZINYL-ALKYL-AZOLES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.
FR2723091B1 (en) * 1994-07-29 1996-11-08 Esteve Labor Dr TETRAHYDROPYRIDINE- (6,4-HYDROXYPIPERIDINE) ALKYLAZOLES

Also Published As

Publication number Publication date
AR004378A1 (en) 1998-11-04
ES2134709B1 (en) 2000-05-16
CZ255197A3 (en) 1998-01-14
EP0808166A1 (en) 1997-11-26
AU1376497A (en) 1997-07-03
IL121461A0 (en) 1998-02-08
MX9706133A (en) 1997-11-29
HUP9800198A2 (en) 1999-09-28
FR2742052B1 (en) 1998-04-10
AU716665B2 (en) 2000-03-02
NO973589D0 (en) 1997-08-04
CA2211161A1 (en) 1997-06-19
ZA9610457B (en) 1997-06-24
PL321779A1 (en) 1997-12-22
WO1997021439A1 (en) 1997-06-19
JPH11501051A (en) 1999-01-26
FR2742052A1 (en) 1997-06-13
CN1177297A (en) 1998-03-25
ES2134709A1 (en) 1999-10-01
TR199700794T1 (en) 1997-11-21

Similar Documents

Publication Publication Date Title
NO973589L (en) Drugs for the treatment of obsessive-compulsive disorder, sleep apnea, sexual dysfunction, emesis and travel sickness
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
MA27702A1 (en) PREPARATION OF STERILE AQUEOUS SUSPENSIONS COMPRISING MICRONIZED CRYSTALLINE ACTIVE INGREDIENTS INTENDED FOR INHALATION
KR960700059A (en) APPLICATION OF CARBAMAZEPINE AND OXCARBAZEPINE IN THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES)
RO117145B1 (en) Mucoadhesive emulsion or aqueous solution
BG101118A (en) Therapeutical compounds
NO20055880L (en) Memantine oral dosage forms
NO980848D0 (en) Piperazine derivatives as neurokinin antagonists
DE122006000057I2 (en) PROTEIN-INGREDIENT MEDICINES
RU2218917C2 (en) Application of specific antagonist of 5ht2a-receptors for preparing drugs useful for treatment of sleep apnea syndrome
PT1067934E (en) ANTI-DEPRESSIVE LIQUID ORAL SOLUTION
MX9805141A (en) USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR THE PREPARATION OF A DRUG FOR RESPIRATORY STIMULATION.
MXPA03005221A (en) Pharmaceutical dronedarone composition for parenteral administration.
ZA949332B (en) Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion
NO20015228L (en) Use of saredutant and its pharmaceutically acceptable salts for the manufacture of drugs used to treat or prevent mental disorders, adaptation disorders, or mixed anxiety-depression disorders
EP1393738A4 (en) Drugs for diabetes
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
HUP0300863A2 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide, process for producing it and pharmaceutical composition containing it
KR910015300A (en) Buspyron: Use for the treatment of sleep apnea
MXPA02011533A (en) NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE.
DE69211639D1 (en) NEW CONNECTIONS AND THEIR MEDICAL USE
RU2004112422A (en) ROUVASTATIN IN PREDEDENTIONAL CONDITIONS
SE9000207L (en) MEDICINAL PRODUCTS AND THE USE OF THE SAME
HUP0002905A2 (en) 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
ATE319452T1 (en) MEDICINES FOR EATING DISORDERS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application